CARDIOMYOPATHY UK
Registered charity 1164263 · accounts filings on the Charity Commission register · also registered in Scotland as SC053398 (OSCR)
Cardiomyopathy UK saves lives and reduces the misery caused by the heart muscle disease cardiomyopathy. We want people affected by the disorder to live long and fulfilling lives and work to achieve this by raising awareness of the condition, improving access to quality treatment, promoting clinical research and supporting anyone affected by cardiomyopathy every step of the way.
Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Disability · website · Get email alerts
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net expenditure of £95,276 for the year, resulting in total funds decreasing from £837,961 to £742,685. The trustees confirm that unrestricted reserves at the end of 2024 were equal to just under eight months of normal unrestricted expenditure, which aligns with their stated policy target of six to nine months. The auditor confirmed that the use of the going concern basis of accounting was appropriate with no material uncertainties identified.
Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.
What the accounts disclose
Largest income source: Community & challenge events (45% of income)
“Community & challenge events 45%”
Per its FY2024 accounts as filed with the Charity Commission.
Reserves policy: six to nine months of normal unrestricted expenditure (held: £565k)
“The charity aims to maintain unrestricted reserves at a level that equates to around six to nine months of normal unrestricted expenditure.”
Per its FY2024 accounts as filed with the Charity Commission.
Accounts audited by Hodson & Co. Discloses 4 of 6 completeness components.
Year-over-year changes
- Reserves position vs the charity's own policy moved from "above" (FY2023) to "within" (FY2024).
Comparing this charity’s FY2023 and FY2024 accounts as analysed by this site.
Public fundraising profile: JustGiving — Cardiomyopathy UK (matched by registered charity number).
Leadership, per the charity’s website
- Katharine McIntosh — Chief Executive Officer (source)
Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.
Funders the charity credits
Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).
- Alexander Jansons Fund — “We were able to award a grant of £120,000 through the Alexander Jansons Fund, Additional funds were raised through a Crowdfunder campaign.” (source page)
- British Heart Foundation — “The CureHeart team were winners of The British Heart Foundation's Big Beat Challenge and were awarded a £30 million research grant by the ch…” (source page)
- Arrhythmogenic Cardiomyopathy Trust — “In 2020 we worked with the Arrhythmogenic Cardiomyopathy Trust to fund a two year research project at University College London.” (source page)
Public profiles (found on the charity’s own website): facebook · instagram
Structured financials (annual return, FY ending 31/12/2024)
Cost of raising funds
£327k
Reported reserves equal ~5.9 months of spending — above the median for charities its size (median 4.8 months; benchmarks).
Per its annual return, cost of raising funds: 31.0% of total income — in the top quarter for charities its size (median 5.2%) (benchmarks).
Register events
- Received assets from another charity (25/08/2022) — per the register’s event history; asset transfers typically record mergers or reorganisations.
- Received assets from another charity (18/04/2019) — per the register’s event history; asset transfers typically record mergers or reorganisations.
- Received assets from another charity (14/12/2016) — per the register’s event history; asset transfers typically record mergers or reorganisations.
- Alyson Smith
- Betsy Thomas
- Mark Anthony Rees
- Martin Bloom
- Peter Thomas
- Stephen Kirkham MC
- TINA AMISS
- Teofila Bueser
Trustee list from the Charity Commission register (current, not historical).
Operates in: Throughout England And Wales
Income and spending
Common questions
Is CARDIOMYOPATHY UK financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net expenditure of £95,276 for the year, resulting in total funds decreasing from £837,961 to £742,685. The trustees confirm that unrestricted reserves at the end of 2024 were equal to just under eight months of normal unrestricted expenditure, which aligns with their stated policy target of six to nine months. The auditor confirmed that the use of the going concern basis of accounting was appropriate with no material uncertainties identified. Its FY2024 accounts were audited by Hodson & Co.
Who funds CARDIOMYOPATHY UK?
Funders whose own accounts filings name CARDIOMYOPATHY UK as a grant recipient include THE SWALLOW TRUST, THE NORTON ROSE FULBRIGHT CHARITABLE FOUNDATION, THE DU BROW CHARITY, TWODS LIMITED, THE PAROCHIAL CHURCH COUNCIL OF THE ECCLESIASTICAL PARISH OF ST SEBASTIAN, WOKINGHAM.
Known funders
Grants to this charity found in funders’ own accounts filings.
Government & lottery funding
Grants to this charity published as open data by government and lottery funders (360Giving).
Funders of similar charities
Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.
Charities like this
Semantically similar by activities and financial character, from our analysed corpus. Compare with HEART RESEARCH UK.
Side by side with its peers
Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.